HUL, Glenmark Pharma surge up to 10% on VWash dealFollowing the announcement, the stock rose 10 per cent to hit a high of Rs 2,059.80 on BSE.
GSK consumer MD to head residual business post HUL deal completionThe unlisted entity has brands like Sensodyne toothpaste, Crocin analgesic and Iodex pain balm. The majority of GSK Consumer’s India portfo...
GSK-Pfizer combo likely to be booster dose for brands in IndiaGSK and Pfizer said on Wednesday they will merge their consumer healthcare businesses, which have combined sales of $12 billion, by creatin...
With $3.4B cash bid, Unilever may bag GSK’s nutrition businessThe deal, if finalised, will strengthen Unilever’s position in India, its most important emerging market.
Demand muted because of economic factors: GSK Consumer MD Manoj Kumar"We've expanded foods where we can get the best returns, but as of now, it's in select markets. Foods business contributes close to 6% of o...
PNB's debt recast S4A scheme is not a Crocin to cure headache, says Usha AnanthasubramaniumWe have taken a conscious decision not to take up fresh proposals of sectors that are not doing well, says managing director of PNB, Usha A...
GSK Healthcare banks on Sensodyne, Crocin to drive growth in IndiaIn India, the power brands will be Sensodyne, Panadol (called Crocin in India), nasal decongestant Otrivin and Voltaren pain relieving gels...
GSK halts invoicing of Crocin Cold and FluHealth foods and consumer goods maker GSK Consumer has stopped sale of Crocin Cold & Flu, after the Government announced a ban on sale of f...
Arvind Kejriwal's mention of Crocin in swearing-in speech trends on TwitterKejriwal had been suffering from fever for the past two days and in his speech after taking oath as the Chief Minister, he said he had come...
GSK slashes price of Crocin tabletsGSKAP takes care of all non-nutrition products whereas GSK Consumer Healthcare is a listed entity which deals only in nutritional products.
Glaxo decides to cut price of Crocin by 50 per centGlaxo had stopped manufacturing Crocin from September 2012, and had launched the variant 'Crocin Advance' at a higher price.
Our ad claims’ll be based on science and facts: Zubair Ahmed, Glaxosmithkline Consumer HealthcareThe maker of Horlicks health food drink and Crocin analgesics will also back its advertising with scientific credentials.
- GlaxoSmithKline Consumer Q1 net up 19% at Rs 156 cr
GlaxoSmithKline Consumer Healthcare Ltd today posted 19 per cent increase in profit after tax at Rs 156 crore for the first quarter ended M...
GlaxoSmithKline's Boost ties up with F1 Vodafone McLaren Mercedes teamConsumer goods firm GlaxoSmithKline (GSK) said its brand Boost has tied up with Formula 1 Vodafone McLaren Mercedes team for the Indian Gra...
- GlaxoSmithKline Consumer Healthcare Q2 net up 29% to Rs 106 crore
GlaxoSmithKline Consumer Healthcare today reported a 29.3 per cent rise in net profit at Rs 106.60 crore for the second quarter ended June.
- GlaxoSmithKline Consumer Healthcare Limited Q4 net up 15%
GlaxoSmithKline Consumer Healthcare Limited (GSKCH), makers of the 'Horlicks' brand of health drinks and foods, today posted a 15% growth i...
- GSK eyes buys to double revenue
Glaxosmithkline Consumer Healthcare (GSKCH) is ready to shift into the top gear in India.